ANDA 71555, held by Abbott. Sodium Nitroprusside.
As of Nov 16, 2026, ANDA 71555 (Nitropress), held by Abbott, was first approved by FDA on Nov 16, 1987, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 16, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nitropress50MG/VIAL ยท injectable;injection | Sodium Nitroprusside | Discontinued |
| Jan 27, 1997 | Supplement 1Labeling | Approved | None posted |
| Feb 3, 1992 | Supplement 3Labeling | Approved | None posted |
| Dec 7, 1990 | Supplement 2Labeling | Approved | None posted |
| Nov 16, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters